Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Vesomni vs Co-administered Components
NCT02634489Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of solifenacin + tamsulosin in benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) (2 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Curve tau at Day 12 and Maximum Plasma Concentration at Day 12. Started Mar 2009; status: completed.
02
Drugs
solifenacin + tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT02634489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634489.